The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Global, randomized, phase III study of tislelizumab plus chemotherapy versus placebo plus chemotherapy as first-line treatment for advanced/metastatic esophageal squamous cell carcinoma (RATIONALE-306 update): Minimum 3-year survival follow-up.
 
Harry H. Yoon
Consulting or Advisory Role - ALX ONCOLOGY; Amgen (Inst); Astellas Scientific and Medical Affairs Inc; Astellas Scientific and Medical Affairs Inc; AstraZeneca; AstraZeneca (Inst); beigene; BeiGene (Inst); Bristol-Myers Squibb (Inst); Elevation Oncology; LSK Biopharma (Inst); Macrogenics (Inst); Merck (Inst); Merck (Inst); Novartis; Novartis (Inst); OncXerna Therapeutics; Zymeworks (Inst)
Research Funding - BeiGene (Inst); Boston Biomedical (Inst); Bristol Myers Squibb Foundation (Inst); CARsgen Therapeutics (Inst); Lilly/ImClone (Inst); Merck (Inst); Roche/Genentech (Inst)
Travel, Accommodations, Expenses - beigene
 
Ken Kato
Honoraria - BMS; Lilly; Ono Pharmaceutical
Consulting or Advisory Role - Bayer; BeiGene; MSD; Oncolys BioPharma; Ono Pharmaceutical
Speakers' Bureau - Bristol-Myers Squibb Japan; MSD; Ono Pharmaceutical
Research Funding - AstraZeneca (Inst); Bayer (Inst); Beigene (Inst); Chugai Pharma (Inst); MSD Oncology (Inst); Ono Pharmaceutical (Inst); Shionogi (Inst); Taiho Pharmaceutical (Inst)
 
Eric Raymond
No Relationships to Disclose
 
Richard Hubner
Consulting or Advisory Role - AstraZeneca; MSD; Novartis/Pfizer
Speakers' Bureau - Eisai
Travel, Accommodations, Expenses - Roche
 
Yongqian Shu
No Relationships to Disclose
 
Yueyin Pan
No Relationships to Disclose
 
Yi Jiang
No Relationships to Disclose
 
Jingdong Zhang
No Relationships to Disclose
 
Sook Ryun Park
Honoraria - BMS Korea; MSD
Consulting or Advisory Role - BeiGene; Pfizer Pharmaceuticals Korea Ltd.
Research Funding - ImmuneOncia (Inst); Incyte (Inst); Ono Pharmaceutical
 
Takashi Kojima
Honoraria - AstraZeneca; Boehringer Ingelheim; Bristol-Myers Squibb; Covidien; EA Pharma; Japan Esophageal Society; Japanese Society of Pharmaceutical Health Care and Sciences; Kyowa Kirin International; Liang Yi Hui Healthcare; MSD; Ono Pharmaceutical; Taiho Pharmaceutical
Consulting or Advisory Role - Boehringer Ingelheim; CMIC; NPT Co.,Ltd.
Research Funding - Astellas Amgen BioPharama (Inst); AstraZeneca (Inst); BeiGene (Inst); Chugai Pharma (Inst); MSD (Inst); Ono Pharmaceutical (Inst); Taiho Pharmaceutical (Inst)
 
Chen-Yuan Lin
No Relationships to Disclose
 
Lucjan S. Wyrwicz
Honoraria - BeiGene; BMS; MSD
Consulting or Advisory Role - GlaxoSmithKline; SERVIER
Speakers' Bureau - BMS
Travel, Accommodations, Expenses - SERVIER
 
David Tougeron
Honoraria - Amgen; AstraZeneca; Bristol-Myers Squibb; Bristol-Myers Squibb; Merck Serono; MSD; Pierre Fabre; Roche; Sanofi; Servier/Pfizer; Takeda
Consulting or Advisory Role - AstraZeneca; BMS; MSD; Novartis; Pierre Fabre; Sanofi; SERVIER; Takeda
Research Funding - BTG (Inst); MSD (Inst); Pierre Fabre (Inst); Roche (Inst); Takeda (Inst)
Travel, Accommodations, Expenses - Amgen; Bristol-Myers Squibb; MSD Oncology; Pierre Fabre; Roche; SERVIER
 
Ryu Ishihara
Honoraria - AI Medical Service; AstraZeneca; Daiichi- Sankyo; Fujifilm; Miyarisan Pharmaceutical; MSD; Olympus; Ono Pharmaceutical (Inst)
 
Liyun Li
Employment - BeiGene
Stock and Other Ownership Interests - BeiGene
Travel, Accommodations, Expenses - BeiGene
 
Hongqian Wu
Employment - BeiGene
Stock and Other Ownership Interests - BeiGene
Travel, Accommodations, Expenses - BeiGene
 
Yanyan Peng
Employment - BeiGene
Stock and Other Ownership Interests - BeiGene
 
Shican Yan
Employment - BeiGene
Stock and Other Ownership Interests - BeiGene
 
Jianming Xu
No Relationships to Disclose